Limited copy number - high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 8 (1) , 82
- https://doi.org/10.1186/1476-4598-8-82
Abstract
Mutation detection in clinical tumour samples is challenging when the proportion of tumour cells, and thus mutant alleles, is low. The limited sensitivity of conventional sequencing necessitates the adoption of more sensitive approaches. High resolution melting (HRM) is more sensitive than sequencing but identification of the mutation is desirable, particularly when it is important to discriminate false positives due to PCR errors or template degradation from true mutations.This publication has 39 references indexed in Scilit:
- Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinibCancer Science, 2008
- Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung CancersPLoS Medicine, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung CancerClinical Cancer Research, 2006
- Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencingNature Medicine, 2006
- A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation ScreeningClinical Cancer Research, 2006
- Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assayLung Cancer, 2005
- Biomarkers in Cancer Staging, Prognosis and Treatment SelectionNature Reviews Cancer, 2005
- Sensitive Sequencing Method for KRAS Mutation Detection by PyrosequencingThe Journal of Molecular Diagnostics, 2005
- EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic TreatmentJournal of Clinical Oncology, 2005